ABSTRACT:
Garlic (Allium sativum L.) is a type of vegetable that is commonly consumed and plays an important role in culinary purposes, as a food additive, and in traditional medicine. The bioactive compounds in garlic, such as allicin, alliin, diallyl sulfide, diallyl disulfide, diallyl trisulfide, and ajoene, have indicated pharmacological effects, particularly on anti-diabetic properties. This study aimed to reveal the potential mechanism of action of bioactive compounds in garlic involved in anti-diabetic properties through a computational approach with reverse docking and molecular dynamics (MD) simulations. Of the 7 proteins known as the target of anti-diabetic drugs, alliin showed the highest docking score compared to other bioactive compounds. In terms of ligand-protein interaction, the interaction of alliin with dipeptidyl peptidase-4 (DPP-4) was similar to the native ligand of DPP-4 compared to alliin and other target proteins. Alliin formed hydrogen bonds with Glu205 and Glu206 which are essential for the inhibitory effect on DPP-4. Furthermore, MD simulations revealed a shift in the position of Alliin in the DPP-4 binding cavity at the end of the simulation. Interestingly, hydrogen bonds between Alliin and Glu205, and Glu206 remained formed. This result provided insight into the potential of bioactive compounds from garlic, alliin, acting as anti-diabetic properties through inhibition of DPP-4.
Cite this article:
Salam R.. Uncovering The Potential Mechanism of Action of Garlic as an Anti-Diabetic: A Computational Approach. Research Journal Pharmacy and Technology. 2025;18(12):5675-1. doi: 10.52711/0974-360X.2025.00820
Cite(Electronic):
Salam R.. Uncovering The Potential Mechanism of Action of Garlic as an Anti-Diabetic: A Computational Approach. Research Journal Pharmacy and Technology. 2025;18(12):5675-1. doi: 10.52711/0974-360X.2025.00820 Available on: https://rjptonline.org/AbstractView.aspx?PID=2025-18-12-10
REFERENCES:
1. Cardelle-Cobas, A., et al., A comprehensive survey of garlic functionality. 2009, Nova Science Publishers.
2. Nidhiya, I., et al., Comparative Antioxidant Activity of Three Garlic Varieties: An in vitro Study. Research Journal of Pharmacognosy and Phytochemistry. 2011; 3(4): 162-165.
3. Ashraf, R., R.A. Khan, and I. Ashraf, Garlic (Allium sativum) supplementation with standard antidiabetic agent provides better diabetic control in type 2 diabetes patients. Pak J Pharm Sci. 2011; 24(4): 565-70.
4. Fadheel, Q.J., A comparative study of the effect of metformin and metformin plus garlic on blood glucose level in patients with type 2 diabetes mellitus in Iraq. Research Journal of Pharmacy and Technology. 2019; 12(4): 1806-1810.
5. Eidi, A., M. Eidi, and E. Esmaeili, Antidiabetic effect of garlic (Allium sativum L.) in normal and streptozotocin-induced diabetic rats. Phytomedicine. 2006; 13(9): 624-629.
6. Fenwick, G.R. and A.B. Hanley, The genus Allium--Part 3. Crit Rev Food Sci Nutr. 1985; 23(1): 1-73.
7. Sanie-Jahromi, F., Z. Zia, and M. Afarid, A review on the effect of garlic on diabetes, BDNF, and VEGF as a potential treatment for diabetic retinopathy. Chin Med. 2023; 18(1): 18.
8. Haider, R., Garlic: The Mystical Food in Health Promotion. 2024.
9. Thangapandian, S., et al., Ligand and structure-based pharmacophore modeling to facilitate novel histone deacetylase 8 inhibitor design. European Journal of Medicinal Chemistry. 2010; 45(10): 4409-4417.
10. Trott, O. and A.J. Olson, AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem. 2010; 31(2): 455-61.
11. Morris, G.M., et al., AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility. Journal of Computational Chemistry. 2009; 30(16): 2785-2791.
12. Malik, A., et al., Molecular docking, synthesis, α-amylase inhibition, urease inhibition and antioxidant evaluation of 4-hydroxy-3-methoxy benzoic acid derivatives. Research Journal of Pharmacy and Technology. 2019; 12(12): 5653-5663.
13. Burley, S.K., et al., RCSB Protein Data Bank: powerful new tools for exploring 3D structures of biological macromolecules for basic and applied research and education in fundamental biology, biomedicine, biotechnology, bioengineering and energy sciences. Nucleic Acids Research. 2021; 49(D1): D437-D451.
14. Pawar, S., et al., Molecular docking using different tools. Asian Journal of Pharmaceutical Research. 2023; 13(4): 292-296.
15. Baul, H.S. and M. Rajiniraja, Favorable binding of quercetin to α-synuclein as potential target in Parkinson disease: an insilico approach. Research Journal of Pharmacy and Technology. 2018: 11(1): 203-206.
16. Pettersen, E.F., et al., UCSF Chimera—a visualization system for exploratory research and analysis. Journal of Computational Chemistry. 2004; 25(13): 1605-1612.
17. Van Der Spoel, D., et al., GROMACS: fast, flexible, and free. Journal of Computational Chemistry. 2005; 26(16): 1701-1718.
18. Kesavan, K. and S. Jayanthi, Structure Based Virtual Screening and Molecular Dynamics Studies to Identify Novel APE1 Inhibitor from Seaweeds as Anti-glioma Agent. Research Journal of Pharmacy and Technology. 2017; 10(8): 2474-2478.
19. Huang, J. and A.D. MacKerell Jr, CHARMM36 all‐atom additive protein force field: Validation based on comparison to NMR data. Journal of Computational Chemistry. 2013; 34(25): 2135-2145.
20. Hanwell, M.D., et al., Avogadro: an advanced semantic chemical editor, visualization, and analysis platform. Journal of Cheminformatics. 2012; 4: 1-17.
21. Vanommeslaeghe, K., E.P. Raman, and A.D. MacKerell Jr, Automation of the CHARMM General Force Field (CGenFF) II: assignment of bonded parameters and partial atomic charges. Journal of Chemical Information and Modeling. 2012; 52(12): 3155-3168.
22. Parrinello, M. and A. Rahman, Polymorphic transitions in single crystals: A new molecular dynamics method. Journal of Applied Physics. 1981; 52(12): 7182-7190.
23. Jayasurya, S.S., et al., Identification of ZAP-70 Inhibitor from Macroalgae through Docking and Molecular Dynamics Studies. Research Journal of Pharmacy and Technology. 2017; 10(12): 4162-4166.
24. Anbarasu, K., D. Senthilkumar, and S. Jayanthi, Deciphering the impact of R324L Mutation in Polycystin-1PKD Domain associated with Autosomal Dominant Polycystic Kidney Disease (ADPKD): A Molecular Dynamics Perspective. Research Journal of Pharmacy and Technology. 2017; 10(9): 3089-3094.
25. Hevener, K.E., et al., Validation of molecular docking programs for virtual screening against dihydropteroate synthase. J Chem Inf Model. 2009; 49(2): 444-60.
26. Sahu, R., S. Jain, and D. Jain, Design of some Apigenin derivatives as selective DPP-IV Inhibitors by Pharmacophore Modelling and its Validation through Molecular Dynamics Simulation. Research Journal of Pharmacy and Technology. 2023; 16(8): 3535-3543.
27. Xue, Q., et al., Evaluation of the binding performance of flavonoids to estrogen receptor alpha by Autodock, Autodock Vina and Surflex-Dock. Ecotoxicology and Environmental Safety. 2022; 233: 113323.
28. McConkey, B.J., V. Sobolev, and M. Edelman, The performance of current methods in ligand–protein docking. Current Science. 2002: 845-856.
29. Arulmozhiraja, S., et al., Comparative Binding Analysis of Dipeptidyl Peptidase IV (DPP-4) with Antidiabetic Drugs - An Ab Initio Fragment Molecular Orbital Study. PLoS One. 2016; 11(11): e0166275.
30. Kim, D., et al., (2R)-4-Oxo-4-[3-(Trifluoromethyl)-5,6-dihydro[1,2,4] triazolo[4,3-a]pyrazin- 7(8H)-yl]-1-(2,4,5-trifluorophenyl)butan-2-amine: A Potent, Orally Active Dipeptidyl Peptidase IV Inhibitor for the Treatment of Type 2 Diabetes. Journal of Medicinal Chemistry. 2005; 48(1): 141-151.